oral glp-1 meds Eli Lilly Gets Speedy FDA Nod for Drug, a Competitor to New Novo Nordisk Pill No prescription New oral GLP-1 drug delivers

Shaking can damage the delicate peptide molecules and lead to aggregation

Fructus Ligustri Lucidi inhibits ferroptosis in ovariectomy-induced osteoporosis in rats via the Nrf2/HO-1 signaling pathway

Ultrasonographic examination of the uterus of ewes during the post-partum period

Transporting these LCFAs through the cell so that they may serve these many roles is thus imperative for the cell to do

doi: 10.3389/fphar.2025.1632588 Received 21 May 2025 Accepted 28 July 2025 Published 29 August 2025 Volume 16 - 2025 Edited by Yurong Lai, Gilead, United States Reviewed by Daniel Crona, University of North Carolina at Chapel Hill, United States John Prybylski, Pfizer, United States Updates Copyright 2025 Cao, Qian, Wang, Zheng, Huang, Wei, Jiang, Yu, Jiang, Yu, Mao and Zhai